Hepatic ploidy, nuclearity, and distribution of DNA synthesis: A comparison of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens

Toxicology and Applied Pharmacology

Volumn 144, Issue 2, 1997, Pages 287-293

  Hasmall, Susan C ^a   Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DICHLOROBENZENE; CHLORENDIC ACID; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PLOIDY; RAT;

EID: 0031172481     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8133     Document Type: Article

References (27)

1. Ashby, J., Brady, A., Elcombe, C. R., Elliot, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., and Purchase, I. F. H. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13, S1-S117.
2. Berry, M. N., and Friend, D. S. (1969). High yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J. Cell Biol. 43, 506-520.
3. Brodsky, W. Y., and Uryvaeva, I. V. (1977). Cell ploidy: Its relation to tissue growth and function. Int. Rev. Cytol. 50, 275-332.
4. Conway, J. G., Cattley, R. C., Popp, J. A., and Butterworth, B. E. (1989). Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexylphthalate). Drug Metab. Rev. 21, 65-102.
5. Eacho, P. I., Lanier, T. C., and Brodhecker, C. A. (1991). Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of Wyeth-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis 12, 1557-1561.
6. Eldridge, S. R., Goldsworthy, T. L., Popp, J. A., and Butterworth, B. E. (1992). Mitogenic stimulation of hepatocellular proliferation in rodents following 1,4-dichlorobenzene administration. Carcinogenesis 13, 409-415.
7. Klaunig, J. E., Siglin, J. C., Schafer, L. D., Hartnett, J. A., Weghorst, C. M., Olsen, M. J., and Hampton, J. A. (1991). Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis. In Chemically Induced Cell Proliferation: Implications for Risk Assessment (B. E. Butterworth, T. J. Slaga, W. Farland, and M. McClain Eds.), pp. 185-194. Wiley-Liss, New York.
8. Marsman, D. S., Cattley, R. C., Conway, J. G., and Popp, J. A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinyl-thio]acetic acid (Wy-14,643) in rats. Cancer Res. 48, 6739-6744.
9. Melchiorri, C., Chieco, P., Zedda, A. I., Coni, P., Ledda-Columbano, G. M., and Columbano, A. (1993). Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen-induced liver growth. Carcinogenesis 14, 1825-1830.
10. Melnick, R. L. (1992). Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6, 2698-2706.
11. Millar, R. T., Shah, R. S., Cattley, R. C., and Popp, J. A. (1996). The peroxisome proliferators Wy-14,643 and Methyclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats. Toxicol. Appl. Pharmacol. 138, 317-323.
12. 1 Mice (Feed Study). NTP TR 217. NIH Publication No. 82-1773.
13. 1 Mice. NTP TR 319. NIH Publication No. 87-2575.
14. 1 Mice (Feed Study). NTP TR 304. NIH Publication No. 87-2560.
15. Nelder, J. A., and Wedderburn, R. W. M. (1972). Generalised linear models. J. Roy. Statist. Soc. 135, 370-384.
16. Odum, J., Foster, J. R., Hasmall, S. C., Tittensor, S., Soames, A. R., and Elcombe, C. R. (1977). Markers of non-genotoxic carcinogenesis. 2. F344 rat liver. Hum. Exp. Toxicol. 16, 15.
17. Rao, M. S., and Reddy, J. K. (1987). Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 8, 631-636.
18. Richardson, F. C., Copple, D. M., Helvering, L. M., Richardson, V. K., and Eacho, P. I. (1992). DNA synthesis in livers of rats and mice exposed to methapyrilene. Proc. Am. Assoc. Cancer Res. 33, 709.
19. SAS Institute Inc. (1989). SAS/STAT User's Guide, Version 6, Fourth Edition, Vol. 2. SAS Institute Inc., Gary, NC.
20. Schulte-Hermann, R. (1974). Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit. Rev. Toxicol. 3, 97-158.
21. Schulte-Hermann, R., Hoffmann, V., and Landgraf, H. (1980). Adaptive responses of the rat liver to the gestagen and antiandrogen cyproterone acetate and other inducers. III. Cytological changes. Chem.-Biol. Interactions 31, 301-311.
22. Styles, J. A., Kelly, M., and Elcombe, C. R. (1987). A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver. Carcinogenesis 8, 391-399.
23. Styles, J. A., Elliot, B. M., Lefevre, P.A., Robinson, M., Pritchard, N., Hart, D., and Ashby, J. (1985). Irreversible depression in the ratio of tetraploid:diploid liver nuclei in rats treated with 3′-methyl-4-dimethylaminoazobenzene (3′ M). Carcinogenesis 6, 21-28.
24. Styles, J. A., Kelly, M., Pritchard, N. R., and Elcombe, C. R. (1988). A species comparison of acute hyperplasia induced by the peroxisome proliferator methyclofenapate: Involvement of the binucleated hepatocyte. Carcinogenesis 9, 1647-1655.
25. Wada, N., Marsman, D. S., and Popp, J. A. (1992). Dose-related effects of the hepatocarcinogen, Wy-14643, on peroxisomes and cell replication. Fundam. Appl. Toxicol. 18, 149-154.
26. Ward, J. M., Hagiwara, A., Anderson, L. M., Lindsey, K., and Diwan, B. A. (1988). The chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital and phenobarbital in male B6C3F1 mice: Autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol. Appl. Pharmacol. 96, 494-506.
27. Yelandi, A. V., Milano, M., Subbarao, V., Reddy, J. K., and Rao, M. S. (1989). Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett. 47, 21-27.